Form 4: Fulgent Genetics CFO Paul Kim Sells Shares to Cover Tax Obligations
SEC Form 4
Fulgent Genetics CFO Paul Kim sold 1,674 shares of common stock on September 3, 2024, to cover tax obligations arising from the vesting of restricted stock units.
Summary
- On September 3, 2024, Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., sold 1,674 shares of the company's common stock.
- The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted on February 28, 2022.
- The shares were sold at prices ranging from $21.815 to $22.10, with a weighted-average sale price of $21.961.
- Following the transaction, Kim directly owns 209,481 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction to cover tax obligations.
Industry Context
This is a routine Form 4 filing related to insider transactions. It is common for executives to sell shares to cover tax obligations arising from the vesting of stock awards.
Key Dates
| Date | Description |
|---|---|
| February 28, 2022 | Date of restricted stock units grant to Paul Kim. |
| March 2, 2022 | Original report on Form 4 filed with the U.S. Securities and Exchange Commission. |
| September 3, 2024 | Date of share sale by Paul Kim. |
| September 5, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.